TherapeuticsMD (TXMD) Gross Profit Growth (3y) (2014 - 2023)
TherapeuticsMD (TXMD) Gross Profit Growth (3y) (2014 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 90.13 Bn | 88.27 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.98 Bn | 32.24 Bn | 1.97 Bn | 7.62% |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn | 4.71% |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn | -7.64% |
| 5 | United Therapeutics | 23.08 Bn | 20.93 Bn | 648.10 Mn | 12.55% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.38 Bn | 18.57 Bn | 1.16 Bn | -9.13% |
| 8 | Neurocrine Biosciences | 17.80 Bn | 16.48 Bn | 800.70 Mn | 24.80% |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | 0.95% |
| 10 | TherapeuticsMD | 280,418.39 | -8.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -69.09% |
| Sep 30, 2023 | -26.06% |
| Jun 30, 2023 | -58.91% |
| Mar 31, 2023 | -64.80% |
| Dec 31, 2022 | 73.97% |
| Mar 31, 2022 | 65.65% |
| Dec 31, 2021 | 49.90% |
| Sep 30, 2021 | 93.56% |
| Jun 30, 2021 | 78.66% |
| Mar 31, 2021 | 69.10% |
| Dec 31, 2020 | 68.86% |
| Sep 30, 2020 | 62.88% |
| Jun 30, 2020 | 20.87% |
| Mar 31, 2020 | 42.06% |
| Dec 31, 2019 | 51.06% |
| Sep 30, 2019 | 73.05% |
| Jun 30, 2019 | 13.85% |
| Mar 31, 2019 | -5.91% |
| Dec 31, 2018 | -1.98% |
| Sep 30, 2018 | -11.45% |